1-7 of 7
Dan S. Kaufman, M.D., Ph.D.
Close
Sort by
Journal Articles

Development Of a Preclinical Human Xenograft Model For Myelodysplastic Syndrome In Immunodeficient Mice Expressing Human Growth Factors

George Scaria, MD, PhD, Laura Bendzick, BS, Leonard Shultz, PhD, Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1534.
https://doi.org/10.1182/blood.V122.21.1534.1534
Published: 2013
Journal Articles

The RUNX1-Regulated Cebpa +37 Kb Enhancer Directs Human CD4 Transgene Expression To Long-Term Hematopoietic Stem Cells and Preferentially To Myeloid Compared With Lymphoid Or Erythroid Progenitors

Alan D. Friedman, M.D., Hong Guo, M.D., Ph.D., Ou Ma, Ph.D., Leonard I. Zon, MD, Ilya Shestopalov, Ph.D., Dan S. Kaufman, M.D., Ph.D., Patrick I Ferrell, B.S.
Journal: Blood
Blood (2013) 122 (21): 2442.
https://doi.org/10.1182/blood.V122.21.2442.2442
Published: 2013
Journal Articles

The Regulation Of Central Nervous System Acute Lymphoblastic Leukemia By Natural Killer Cells

Liron Frishman-Levy, Avishai Shemesh, Shahar Frenkel, MD, PhD, Allan Bar-Sinai, PhD, Zhenya Ni, DVM/PhD, Dan S. Kaufman, M.D., Ph.D., Lueder Hinrich Meyer, MD, Gunnar Cario, MD, Jacob Hochman, PhD, Angel Progador, PhD, Shai Izraeli, MD
Journal: Blood
Blood (2013) 122 (21): 1393.
https://doi.org/10.1182/blood.V122.21.1393.1393
Published: 2013
Journal Articles

Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem Cells

David L Hermanson, PhD, Zhenya Ni, DVM/PhD, David A. Knorr, PhD, Laura Bendzick, BS, Lee J Pribyl, BS, Melissa Geller, MD, Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 896.
https://doi.org/10.1182/blood.V122.21.896.896
Published: 2013
Journal Articles

Natural Killer Cells Derived From Human Pluripotent Stem Cells Provide a Novel Method to Treat HIV-1 Infection.

Zhenya Ni, D.V.M., Ph.D., David A. Knorr, Christine L. Clouser, Ph.D., Peter Southern, Ph.D., Louis M. Mansky, Ph.D., In-Hyun Park, Ph.D., Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 280.
https://doi.org/10.1182/blood.V114.22.280.280
Published: 2009
Journal Articles

NK Cells Derived from Human Embryonic Stem Cells Demonstrate More Effective In Vivo Clearance of Xenografted Human Tumor Cells Compared to NK Cells Derived from Cord Blood.

Petter S. Woll, MS, Rebecca Marcus, Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2745.
https://doi.org/10.1182/blood.V110.11.2745.2745
Published: 2007
Journal Articles

Characterization of Hematopoietic Progenitor Cells Derived from Human Embryonic Stem Cells That Differentiate into Natural Killer Cells Capable of In Vivo Anti-Tumor Activity.

Petter S. Woll, MS, Colin H. Martin, Ph.D., Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 645.
https://doi.org/10.1182/blood.V108.11.645.645
Published: 2006